Transitioning innovative cell-based therapies from research environments to GMP-compliant manufacturing presents recurring ...
Precision Biologics Manufacturing breaks ground creating 200-300 jobs and expanding U.S.-based wound care manufacturing in 2026 HENDERSON, NV AND LAS VEGAS, NV / ACCESS Newswire / September 30, 2025 / ...
HOPEWELL, N.J., Aug. 11, 2025 /PRNewswire/ -- ProBio, a leading contract development and manufacturing organization (CDMO) specializing in gene and cell therapy, today announced the launch of its cGMP ...
MONT-SAINT-GUIBERT, Belgium--(BUSINESS WIRE)--Cellistic®, a pioneer in iPSC-based off-the-shelf cell therapy development and manufacturing, announces the successful audit and GMP certification of its ...
Locus Cell (TWSE: 6891), a leading regenerative medicine CDMO in Taiwan, announced it has signed a Memorandum of Understanding (MOU) with Australia-based Cambium Bio (ASX: CMB). Under the agreement, ...
ProBioGen has been selected to operate the process development and GMP production facility for Advanced Therapy Medicinal Products at the Berlin Center for Gene and Cell Therapies.
Hopewell-based team delivers on ProBio's promise of speed, quality, and reliability—offering a transparent, fixed-cost model and ≥85% supercoiled plasmid DNA in record time for clinical programs. At ...
NANJING, China--(BUSINESS WIRE)--GenScript ProBio announced today the opening of China's largest commercial GMP plasmid manufacturing facility during a ceremony at the site in Zhenjiang, Jiangsu ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback